Financial Snapshot

Revenue
$82.57M
TTM
Gross Margin
75.35%
TTM
Net Earnings
-$6.995M
TTM
Current Assets
$57.33M
Q2 2024
Current Liabilities
$51.98M
Q2 2024
Current Ratio
110.28%
Q2 2024
Total Assets
$70.21M
Q2 2024
Total Liabilities
$93.42M
Q2 2024
Book Value
-$23.21M
Q2 2024
Cash
$4.862M
Q2 2024
P/E
-10.85
Nov 29, 2024 EST
Free Cash Flow
-$3.790M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $81.76M $80.06M $69.82M $66.05M $63.22M $45.22M $32.91M $27.92M $23.85M $6.140M $7.380M $13.54M $15.12M $30.81M $15.11M $2.520M $2.890M $1.450M $13.54M $2.020M $2.820M $5.460M $2.910M $2.490M $1.670M $1.200M $740.0K $630.0K
YoY Change 2.13% 14.66% 5.71% 4.48% 39.81% 37.41% 17.87% 17.06% 288.44% -16.8% -45.49% -10.45% -50.93% 103.9% 499.6% -12.8% 99.31% -89.29% 570.3% -28.37% -48.35% 87.63% 16.87% 49.1% 39.17% 62.16% 17.46%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $81.76M $80.06M $69.82M $66.05M $63.22M $45.22M $32.91M $27.92M $23.85M $6.140M $7.380M $13.54M $15.12M $30.81M $15.11M $2.520M $2.890M $1.450M $13.54M $2.020M $2.820M $5.460M $2.910M $2.490M $1.670M $1.200M $740.0K $630.0K
Cost Of Revenue $19.64M $26.28M $23.26M $27.81M $26.08M $13.37M $6.990M $5.010M $3.190M $2.240M $3.620M $5.040M $9.260M $450.0K $0.00 $0.00 $150.0K $360.0K $420.0K $250.0K $150.0K $220.0K
Gross Profit $62.13M $53.78M $46.56M $38.24M $37.14M $31.85M $25.92M $22.90M $20.66M $3.900M $3.750M $8.490M $5.850M $30.36M $15.11M $5.460M $2.760M $2.130M $1.250M $950.0K $590.0K $410.0K
Gross Profit Margin 75.99% 67.17% 66.69% 57.9% 58.75% 70.43% 78.76% 82.02% 86.62% 63.52% 50.81% 62.7% 38.69% 98.54% 100.0% 100.0% 94.85% 85.54% 74.85% 79.17% 79.73% 65.08%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Selling, General & Admin $42.39M $47.54M $40.35M $36.14M $32.40M $25.75M $22.98M $13.25M $12.01M $10.55M $3.970M $6.300M $12.86M $10.10M $11.60M $9.550M $8.850M $5.100M $5.290M $5.850M $5.950M $5.220M $3.810M $3.790M $2.180M $2.330M $2.390M $1.990M
YoY Change -10.83% 17.82% 11.64% 11.54% 25.83% 12.05% 73.43% 10.32% 13.84% 165.74% -36.98% -51.01% 27.33% -12.93% 21.47% 7.91% 73.53% -3.59% -9.57% -1.68% 13.98% 37.01% 0.53% 73.85% -6.44% -2.51% 20.1%
% of Gross Profit 68.22% 88.39% 86.65% 94.51% 87.24% 80.85% 88.66% 57.86% 58.13% 270.51% 105.87% 74.2% 219.83% 33.27% 76.77% 95.6% 138.04% 177.93% 174.4% 245.26% 405.08% 485.37%
Research & Development $30.37M $36.94M $28.27M $18.02M $10.84M $7.990M $9.050M $5.180M $3.850M $5.080M $7.200M $6.330M $11.13M $13.60M $18.01M $31.72M $27.82M $18.59M $11.33M $12.97M $14.85M $15.04M $7.400M $3.040M $2.230M $2.020M $2.250M $1.790M
YoY Change -17.78% 30.65% 56.9% 66.24% 35.67% -11.71% 74.71% 34.55% -24.21% -29.44% 13.74% -43.13% -18.16% -24.49% -43.22% 14.02% 49.65% 64.08% -12.64% -12.66% -1.26% 103.24% 143.42% 36.32% 10.4% -10.22% 25.7%
% of Gross Profit 48.88% 68.69% 60.72% 47.12% 29.19% 25.09% 34.92% 22.62% 18.64% 130.26% 192.0% 74.56% 190.26% 44.8% 119.19% 275.46% 268.12% 142.72% 178.4% 212.63% 381.36% 436.59%
Depreciation & Amortization $3.315M $12.47M $8.748M $8.520M $7.500M $4.230M $1.530M $1.590M $1.520M $1.040M $120.0K $560.0K $340.0K $450.0K $530.0K $5.330M $1.030M $920.0K $1.270M $1.000M $2.310M $1.570M $780.0K $440.0K $320.0K $200.0K $150.0K $80.00K
YoY Change -73.42% 42.56% 2.68% 13.6% 77.3% 176.47% -3.77% 4.61% 46.15% 766.67% -78.57% 64.71% -24.44% -15.09% -90.06% 417.48% 11.96% -27.56% 27.0% -56.71% 47.13% 101.28% 77.27% 37.5% 60.0% 33.33% 87.5%
% of Gross Profit 5.34% 23.19% 18.79% 22.28% 20.19% 13.28% 5.9% 6.94% 7.36% 26.67% 3.2% 6.6% 5.81% 1.48% 3.51% 28.75% 28.26% 20.66% 25.6% 21.05% 25.42% 19.51%
Operating Expenses $42.39M $93.69M $71.80M $57.11M $45.65M $35.52M $33.54M $19.94M $17.37M $15.63M $11.18M $12.63M $24.13M $23.92M $29.60M $41.26M $37.44M $24.24M $17.66M $19.51M $21.30M $21.08M $11.73M $7.130M $4.540M $4.430M $4.720M $4.030M
YoY Change -54.76% 30.48% 25.72% 25.1% 28.52% 5.9% 68.2% 14.8% 11.13% 39.8% -11.48% -47.66% 0.88% -19.19% -28.26% 10.2% 54.46% 37.26% -9.48% -8.4% 1.04% 79.71% 64.52% 57.05% 2.48% -6.14% 17.12%
Operating Profit $19.74M -$39.91M -$25.24M -$18.87M -$8.510M -$3.670M -$7.620M $2.960M $3.290M -$11.73M -$7.430M -$4.140M -$18.28M $6.440M -$14.49M -$15.62M -$8.970M -$5.000M -$3.290M -$3.480M -$4.130M -$3.620M
YoY Change -149.47% 58.14% 33.74% 121.74% 131.88% -51.84% -357.43% -10.03% -128.05% 57.87% 79.47% -77.35% -383.85% -144.44% 74.14% 79.4% 51.98% -5.46% -15.74% 14.09%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Interest Expense -$8.494M -$7.208M -$6.395M -$4.650M -$3.940M -$2.370M -$5.610M -$2.140M -$1.650M -$1.590M $460.0K $930.0K $1.000M $2.320M $1.380M -$50.00K $0.00 -$7.680M -$1.570M -$700.0K $4.450M $25.64M $8.920M -$10.00K -$10.00K $0.00
YoY Change 17.84% 12.71% 37.53% 18.02% 66.24% -57.75% 162.15% 29.7% 3.77% -445.65% -50.54% -7.0% -56.9% 68.12% -100.0% 389.17% 124.29% -115.73% -82.64% 187.44% -89300.0% 0.0%
% of Operating Profit -43.02% -72.3% -50.15% 36.02%
Other Income/Expense, Net -$996.0K -$35.00K -$31.00K -$40.00K -$40.00K -$40.00K -$30.00K -$40.00K $60.00K $3.740M -$10.00K -$20.00K -$20.00K -$20.00K
YoY Change 2745.71% 12.9% -22.5% 0.0% 0.0% 33.33% -25.0% -166.67% -98.4% -37500.0% -50.0% 0.0% 0.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Pretax Income -$23.54M -$46.79M -$31.66M -$22.65M -$12.50M -$5.970M -$14.16M $790.0K $1.700M -$9.580M -$3.940M -$13.90M -$18.03M $8.740M -$13.11M -$45.87M -$34.61M -$22.79M -$11.80M -$19.05M -$20.46M -$11.17M $16.67M $3.910M -$3.300M -$3.490M -$4.140M -$3.620M
YoY Change -49.7% 47.79% 39.79% 81.2% 109.38% -57.84% -1892.41% -53.53% -117.75% 143.15% -71.65% -22.91% -306.29% -166.67% -71.42% 32.53% 51.86% 93.14% -38.06% -6.89% 83.17% -167.01% 326.34% -218.48% -5.44% -15.7% 14.36%
Income Tax $421.0K $443.0K $63.00K $20.00K $0.00 -$1.270M $0.00 $480.0K $450.0K $30.00K $30.00K $0.00 -$70.00K $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $180.0K $0.00 $0.00 -$20.00K $0.00 $0.00 -$260.0K
% Of Pretax Income 60.76% 26.47% 1.26% 0.0% 0.0%
Net Earnings -$23.96M -$47.24M -$31.73M -$22.67M -$12.50M -$4.700M -$14.16M $310.0K $1.250M -$9.610M -$3.960M -$13.91M -$17.95M $8.630M -$13.11M -$45.87M -$34.61M -$22.79M -$11.80M -$17.44M -$23.80M -$9.120M $17.30M $3.910M -$3.270M -$3.490M -$4.140M -$3.460M
YoY Change -49.28% 48.9% 39.94% 81.36% 165.96% -66.81% -4667.74% -75.2% -113.01% 142.68% -71.53% -22.51% -308.0% -165.83% -71.42% 32.53% 51.86% 93.14% -32.34% -26.72% 160.96% -152.72% 342.46% -219.57% -6.3% -15.7% 19.65%
Net Earnings / Revenue -29.3% -59.0% -45.44% -34.32% -19.77% -10.39% -43.03% 1.11% 5.24% -156.51% -53.66% -102.73% -118.72% 28.01% -86.76% -1820.24% -1197.58% -1571.72% -87.15% -863.37% -843.97% -167.03% 594.5% 157.03% -195.81% -290.83% -559.46% -549.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.91 -$0.50 -$343.5K -$294.5K -$162.5K -$61.89K -$192.7K $4.711K $19.79K -$157.5K -$64.91K -$228.1K -$295.6K $140.7K -$217.4K -$798.9K -$658.2K -$526.0K -$332.1K -$505.8K -$772.2K -$297.9K $609.8K $153.5K -$158.0K -$190.2K -$246.0K -$233.0K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Cash & Short-Term Investments $40.39M $33.07M $40.35M $20.80M $40.60M $48.70M $17.90M $5.700M $11.50M $2.800M $1.000M $1.700M $3.200M $27.80M $10.90M $9.000M $30.00M $15.80M $11.70M $15.10M $30.30M $25.10M $32.80M $18.70M $15.10M $10.40M $7.000M $7.600M
YoY Change 22.13% -18.05% 94.01% -48.77% -16.63% 172.07% 214.04% -50.43% 310.71% 180.0% -41.18% -46.88% -88.49% 155.05% 21.11% -70.0% 89.87% 35.04% -22.52% -50.17% 20.72% -23.48% 75.4% 23.84% 45.19% 48.57% -7.89%
Cash & Equivalents $6.290M $9.214M $19.96M $2.600M $0.00 $900.0K $400.0K $0.00 $100.0K $1.600M $900.0K $200.0K $500.0K $7.000M $7.600M
Short-Term Investments $8.000M $12.00M $9.700M $16.50M $4.900M $2.200M $100.0K $100.0K $700.0K $1.800M $9.500M $8.900M $27.50M $15.80M $10.70M $14.80M $30.20M $25.00M $31.30M $17.80M $14.80M $9.800M
Other Short-Term Assets $3.293M $8.268M $11.49M $5.700M $4.500M $2.900M $1.900M $1.300M $1.300M $1.100M $500.0K $1.100M $2.600M $1.200M $600.0K $600.0K $400.0K $300.0K $400.0K $200.0K $500.0K $300.0K $400.0K $200.0K $300.0K $100.0K $0.00 $100.0K
YoY Change -60.17% -28.01% 101.49% 26.67% 55.17% 52.63% 46.15% 0.0% 18.18% 120.0% -54.55% -57.69% 116.67% 100.0% 0.0% 50.0% 33.33% -25.0% 100.0% -60.0% 66.67% -25.0% 100.0% -33.33% 200.0% -100.0%
Inventory $6.066M $19.69M $29.14M $25.10M $20.90M $11.10M $7.200M $9.100M $9.500M $9.300M $10.40M $12.90M $10.10M $4.200M $2.100M $0.00 $2.100M $700.0K $1.700M $1.300M $800.0K $1.300M $700.0K $500.0K $0.00 $200.0K $100.0K $2.300M
Prepaid Expenses
Receivables $12.80M $10.66M $9.261M $10.90M $9.500M $11.00M $7.500M $5.000M $3.400M $2.000M $400.0K $1.100M $1.300M $0.00 $0.00 $0.00 $500.0K $300.0K $200.0K $300.0K $400.0K $400.0K $500.0K $300.0K $300.0K $100.0K $100.0K $2.600M
Other Receivables $753.0K $1.685M $1.667M $2.300M $600.0K $0.00 $100.0K $0.00 $0.00 $100.0K $100.0K $500.0K $800.0K $500.0K $1.600M $1.700M $1.400M $1.600M $900.0K $700.0K $800.0K $1.400M $900.0K $1.200M $700.0K $700.0K $600.0K $600.0K
Total Short-Term Assets $63.30M $73.37M $91.91M $64.80M $76.20M $73.60M $34.60M $21.20M $25.80M $15.30M $12.30M $17.20M $18.10M $33.70M $15.30M $11.20M $34.40M $18.80M $14.70M $17.60M $32.70M $28.50M $35.30M $21.00M $16.40M $11.50M $7.800M $13.20M
YoY Change -13.73% -20.17% 41.83% -14.96% 3.53% 112.72% 63.21% -17.83% 68.63% 24.39% -28.49% -4.97% -46.29% 120.26% 36.61% -67.44% 82.98% 27.89% -16.48% -46.18% 14.74% -19.26% 68.1% 28.05% 42.61% 47.44% -40.91%
Property, Plant & Equipment $1.976M $3.089M $2.854M $3.500M $1.100M $100.0K $0.00 $0.00 $100.0K $100.0K $300.0K $400.0K $1.000M $1.000M $1.200M $1.100M $1.700M $1.400M $1.800M $1.900M $4.100M $4.800M $1.700M $1.000M $400.0K $400.0K $300.0K $2.900M
YoY Change -36.03% 8.23% -18.46% 218.18% 1000.0% -100.0% 0.0% -66.67% -25.0% -60.0% 0.0% -16.67% 9.09% -35.29% 21.43% -22.22% -5.26% -53.66% -14.58% 182.35% 70.0% 150.0% 0.0% 33.33% -89.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $600.0K $5.200M $7.700M $2.900M $0.00 $10.60M $19.00M $32.80M $35.10M $49.10M $28.50M $31.00M $16.20M $22.50M $31.10M $28.40M $42.90M $43.50M $27.40M $800.0K $0.00
YoY Change -100.0% -88.46% -32.47% 165.52% -100.0% -44.21% -42.07% -6.55% -28.51% 72.28% -8.06% 91.36% -28.0% -27.65% 9.51% -33.8% -1.38% 58.76% 3325.0%
Other Assets $0.00 $1.792M $621.0K $200.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $0.00
YoY Change -100.0% 188.57% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Long-Term Assets $14.47M $19.89M $27.30M $35.30M $41.40M $37.50M $24.60M $18.20M $11.70M $13.30M $11.10M $19.30M $33.80M $36.10M $50.20M $31.90M $40.20M $25.90M $31.30M $39.70M $40.10M $61.30M $55.10M $34.00M $2.000M $1.000M $700.0K $3.000M
YoY Change -27.24% -27.15% -22.65% -14.73% 10.4% 52.44% 35.16% 55.56% -12.03% 19.82% -42.49% -42.9% -6.37% -28.09% 57.37% -20.65% 55.21% -17.25% -21.16% -1.0% -34.58% 11.25% 62.06% 1600.0% 100.0% 42.86% -76.67%
Total Assets $77.77M $93.26M $119.2M $100.1M $117.6M $111.1M $59.20M $39.40M $37.50M $28.60M $23.40M $36.50M $51.90M $69.80M $65.50M $43.10M $74.60M $44.70M $46.00M $57.30M $72.80M $89.80M $90.40M $55.00M $18.40M $12.50M $8.500M $16.20M
YoY Change
Accounts Payable $6.990M $12.89M $15.53M $17.50M $13.10M $25.80M $5.400M $2.300M $2.400M $1.600M $500.0K $1.500M $3.400M $1.000M $1.900M $200.0K $8.600M $5.700M $4.000M $4.200M $5.500M $5.900M $5.000M $2.600M $1.100M $900.0K $900.0K $2.800M
YoY Change -45.76% -17.0% -11.28% 33.59% -49.22% 377.78% 134.78% -4.17% 50.0% 220.0% -66.67% -55.88% 240.0% -47.37% 850.0% -97.67% 50.88% 42.5% -4.76% -23.64% -6.78% 18.0% 92.31% 136.36% 22.22% 0.0% -67.86%
Accrued Expenses $19.95M $24.74M $24.14M $16.80M $17.40M $11.50M $4.800M $6.500M $4.600M $2.600M $1.800M $2.000M $2.500M
YoY Change -19.39% 2.5% 43.69% -3.45% 139.58% -26.15% 41.3% 76.92% 44.44% -10.0% -20.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $300.0K
YoY Change -100.0%
Long-Term Debt Due $7.707M $65.27M $463.0K $5.100M $3.400M $0.00 $3.600M $3.500M $3.300M $3.200M
YoY Change -88.19% 13996.11% -90.92% 50.0% -100.0% 2.86% 6.06% 3.13%
Total Short-Term Liabilities $47.29M $114.3M $45.08M $41.90M $37.10M $26.90M $22.20M $11.50M $12.60M $9.900M $4.400M $6.400M $11.30M $11.50M $11.80M $5.600M $8.600M $5.700M $4.000M $4.200M $5.500M $5.900M $5.000M $2.600M $1.100M $1.000M $900.0K $3.200M
YoY Change -58.62% 153.53% 7.58% 12.94% 37.92% 21.17% 93.04% -8.73% 27.27% 125.0% -31.25% -43.36% -1.74% -2.54% 110.71% -34.88% 50.88% 42.5% -4.76% -23.64% -6.78% 18.0% 92.31% 136.36% 10.0% 11.11% -71.88%
Long-Term Debt $51.26M $1.446M $56.28M $55.00M $55.30M $49.20M $3.500M $6.600M $9.400M $11.80M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.300M
YoY Change 3445.02% -97.43% 2.33% -0.54% 12.4% 1305.71% -46.97% -29.79% -20.34% -100.0%
Other Long-Term Liabilities $84.00K $106.0K $94.00K $0.00 $300.0K $0.00 $0.00 $1.300M $500.0K $0.00 $1.600M $7.300M $5.000M $7.000M $13.00M $0.00 $0.00 $2.900M $2.400M $13.50M $13.80M $300.0K $500.0K $600.0K $0.00
YoY Change -20.75% 12.77% -100.0% -100.0% 160.0% -100.0% -78.08% 46.0% -28.57% -46.15% -100.0% 20.83% -82.22% -2.17% 4500.0% -40.0% -16.67%
Total Long-Term Liabilities $51.35M $1.552M $56.38M $55.00M $55.60M $49.20M $3.500M $7.900M $9.900M $11.80M $1.600M $7.300M $5.000M $7.000M $13.00M $0.00 $0.00 $0.00 $0.00 $0.00 $2.900M $2.400M $13.50M $13.80M $300.0K $500.0K $600.0K $1.300M
YoY Change 3208.31% -97.25% 2.5% -1.08% 13.01% 1305.71% -55.7% -20.2% -16.1% 637.5% -78.08% 46.0% -28.57% -46.15% -100.0% 20.83% -82.22% -2.17% 4500.0% -40.0% -16.67% -53.85%
Total Liabilities $98.64M $115.8M $101.5M $96.90M $92.70M $76.10M $25.70M $19.40M $22.50M $21.70M $6.000M $13.70M $16.20M $18.50M $24.70M $5.600M $8.600M $5.700M $4.000M $4.200M $18.60M $24.20M $34.40M $16.40M $1.400M $1.500M $1.500M $4.500M
YoY Change -14.84% 14.17% 4.7% 4.53% 21.81% 196.11% 32.47% -13.78% 3.69% 261.67% -56.2% -15.43% -12.43% -25.1% 341.07% -34.88% 50.88% 42.5% -4.76% -77.42% -23.14% -29.65% 109.76% 1071.43% -6.67% 0.0% -66.67%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $75.867 Million

About Theratechnologies Inc.

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The company is headquartered in Montreal, Quebec and currently employs 103 full-time employees. The firm is focused on the development and commercialization of therapies addressing unmet medical needs. The company markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The firm's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. The company blocks viral entry into host cells while preserving normal immunologic function. The firm is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

Industry: Pharmaceutical Preparations Peers: Aurinia Pharmaceuticals Inc. Fusion Pharmaceuticals Inc. Repare Therapeutics Inc. Xenon Pharmaceuticals Inc. Zymeworks BC Inc.